Advances in Predictive Research of Immune Checkpoint Inhibitors-related
Adverse Events / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 789-794, 2023.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-1010087
Responsible library:
WPRO
ABSTRACT
The era of tumor treatment has been revolutionized by the advent of immune checkpoint inhibitors. However, while immunotherapy benefits patients, it can also lead to immune-related adverse events that may affect multiple organs and systems throughout the body, potentially even posing a life-threatening risk. The diverse clinical manifestations and onset times of these adverse events further complicate their prediction and diagnosis. The purpose of this paper is to review the clinical characteristics and predicted biomarkers of adverse events related to inhibitors at immune checkpoints, in order to help clinicians evaluate drug risks and early warn adverse events.
.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Immune Checkpoint Inhibitors
/
Immunotherapy
/
Lung Neoplasms
/
Neoplasms
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Lung Cancer
Year:
2023
Document type:
Article